Your browser doesn't support javascript.
loading
Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084.
Eshleman, Susan H; Fogel, Jessica M; Piwowar-Manning, Estelle; Chau, Gordon; Cummings, Vanessa; Agyei, Yaw; Richardson, Paul; Sullivan, Philip; Haines, Casey D; Bushman, Lane R; Petropoulos, Christos; Persaud, Deborah; Kofron, Ryan; Hendrix, Craig W; Anderson, Peter L; Farrior, Jennifer; Mellors, John; Adeyeye, Adeola; Rinehart, Alex; St Clair, Marty; Ford, Susan; Rooney, James F; Mathew, Carrie-Anne; Hunidzarira, Portia; Spooner, Elizabeth; Mpendo, Juliet; Nair, Gonasagrie; Cohen, Myron S; Hughes, James P; Hosseinipour, Mina; Hanscom, Brett; Delany-Moretlwe, Sinead; Marzinke, Mark A.
Affiliation
  • Eshleman SH; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Fogel JM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Piwowar-Manning E; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Chau G; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Cummings V; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Agyei Y; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Richardson P; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Sullivan P; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Haines CD; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Bushman LR; Department of Pharmaceutical Sciences, University of Colorado, Aurora, Colorado, USA.
  • Petropoulos C; Monogram Biosciences, South San Francisco, California, USA.
  • Persaud D; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Kofron R; Department of Medicine, University of California at Los Angeles, Los Angeles, California, USA.
  • Hendrix CW; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Anderson PL; Department of Pharmaceutical Sciences, University of Colorado, Aurora, Colorado, USA.
  • Farrior J; FHI 360, Durham, North Carolina, USA.
  • Mellors J; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Adeyeye A; Prevention Science Program, Division of Acquired Immunodeficiency Syndrome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
  • Rinehart A; ViiV Healthcare, Research Triangle Park, North Carolina, USA.
  • St Clair M; ViiV Healthcare, Research Triangle Park, North Carolina, USA.
  • Ford S; GlaxoSmithKline, Research Triangle Park, North Carolina, USA.
  • Rooney JF; Gilead Sciences, Foster City, California, USA.
  • Mathew CA; Wits RHI, University of the Witwatersrand, Johannesburg, South Africa.
  • Hunidzarira P; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.
  • Spooner E; HIV Prevention Research Unit, South African Medical Research Council, Durban, South Africa.
  • Mpendo J; UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.
  • Nair G; Center for Medical Ethics and Law, Stellenbosch University, Stellenbosch, South Africa.
  • Cohen MS; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Hughes JP; Department of Biostatistics, University of Washington, Seattle, Washington, USA.
  • Hosseinipour M; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Hanscom B; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Delany-Moretlwe S; Wits RHI, University of the Witwatersrand, Johannesburg, South Africa.
  • Marzinke MA; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
J Infect Dis ; 225(10): 1741-1749, 2022 05 16.
Article in En | MEDLINE | ID: mdl-35301540
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Pre-Exposure Prophylaxis Limits: Female / Humans Language: En Journal: J Infect Dis Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Pre-Exposure Prophylaxis Limits: Female / Humans Language: En Journal: J Infect Dis Year: 2022 Document type: Article Affiliation country: Country of publication: